{
    "2019-11-14": [
        [
            {
                "time": "2023-10-01",
                "original_text": "Sarepta expands gene therapy push with $90M deal",
                "features": {
                    "keywords": [
                        "Sarepta",
                        "gene therapy",
                        "expands",
                        "$90M deal"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "biotechnology",
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "The Zacks Analyst Blog Highlights: Microsoft, Novartis, Novo Nordisk, Tesla and General Dynamics",
                "features": {
                    "keywords": [
                        "Zacks Analyst Blog",
                        "Microsoft",
                        "Novartis",
                        "Novo Nordisk",
                        "Tesla",
                        "General Dynamics"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "technology",
                        "pharmaceuticals",
                        "automobiles",
                        "defense"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}